KRAS and colorectal cancer: in 2018, where the researchers introduced indels using the CRISPR/Cas9 system, causing frameshift mutations at the KRAS codon-12 sites using colorectal cancer cells (SW480, SW620, SNU407, AS-PC1 cell lines) [106].